Park Ha Biological Technology Co., Ltd. is trading 6.7% down at $1.40 in after-hours trading following the closure of a $2.0 million registered direct stock offering.

  • The capital raise marks the company's second stock offering this year, heightening investor concerns regarding continued share dilution.
  • The downward move follows a sharp multi-day rally, with persistent losses and the fresh capital injection weighing on market sentiment.